Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/27/26 18:17 | 2/7/25 | CNTA | Health | Drug | Pharmaceutical Preparations | Anderson Karen M. | O | Chief Pe | 6 | S.dm | -8,521 | 25.43 | 0 | -335 | 72 | D | ||||||||||||||||
3/26/26 20:36 | 7/25/25 | CNTA | Health | Drug | Pharmaceutical Preparations | Weinhoff Gregory M | O | Chief Bu | 10 | S.d | -3,932 | 21.58 | 0 | -182 | 183 | D | ||||||||||||||||
2/3/26 18:59 | 8/15/25 | CNTA | Health | Drug | Pharmaceutical Preparations | Hussain Iqbal J | X0 | O | GC | 14 | S.dm | -4,283 | 19.15 | 0 | -224 | 131 | D | |||||||||||||||
12/9/25 19:07 | 7/29/25 | CNTA | Health | Drug | Pharmaceutical Preparations | Accardi Mario Alberto | X0 | O | P,Orexin | 7 | S.d | -1,440 | 21.65 | 0 | -66 | 216 | D | |||||||||||||||
11/18/25 16:17 | 2/3/25 | CNTA | Health | Drug | Pharmaceutical Preparations | Bush Tia L | X0 | O | Chief Te | 6 | S.dm | -4,709 | 23.17 | 0 | -203 | 148 | D | |||||||||||||||
7/21/25 19:39 | 7/21/25 | CNTA | Health | Drug | Pharmaceutical Preparations | Saha Saurabh | X0 | DO | CEO | 9 | S.dm | -8,187 | 15.52 | 0 | -527 | 614 | D | |||||||||||||||
3/19/25 16:47 | 3/17/25 | CNTA | Health | Drug | Pharmaceutical Preparations | Chao David M | X0 | O | Chief Ad | 1 | S.d | -120 | 17.17 | 0 | -7 | 225 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |